Corporate Banner
Satellite Banner
Technology Networks Header
Monday, September 01, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
New 1mL ISOLUTE® SLE+ 48-well Plates from Biotage
Tuesday, June 17, 2014
Enabling the extraction of larger sample volumes, faster! Med chem, proteomics, bioprocessing and screening

New Screening Library Offers Exceptional Chemical Diversity to Increase Hit Probability
Thursday, June 12, 2014
Delivering highly diverse coverage of drug-like chemical space in a single library.

Odour Free Evaporation on Users Lab Bench
Wednesday, June 04, 2014
“Odour Reduction” function for Genevac’s EZ-2 evaporator.

Higher Performance from Vacuum Jacketed Reactor System
Wednesday, June 04, 2014
Asynt’s ReactoMate Reactor System provides excellent reaction visibility and reduces condensation.

CCBT at inStem Licenses Cresset’s Computational Tools
Tuesday, June 03, 2014
Three year license to use Forge and Spark software tools for lead optimization and identification.

Embase Enhances Adverse Event Monitoring
Friday, May 30, 2014
With Embase and PharmaPendium, researchers can monitor pre-clinical, clinical and post-market information from a single search - improving pharmacovigilance and risk monitoring.

Extraordinary Tools for Exceptional Results
Wednesday, May 28, 2014
New Rainin Pipet-Lite™ XLS+™ manual pipettes from Anachem.

New Undergrad Hotplate Stirrers from Stuart
Saturday, May 24, 2014
New models deliver upmost levels of control and accuracy.

Malvern Publishes New Whitepaper that Explores AQbD
Friday, May 16, 2014
The whitepaper is freely available for download from http://www.malvern.com/beyond_sops.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 1259
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv